Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Brattea logo — Pioneering advancements in renal denervation for hypertensio...

Brattea

Pioneering advancements in renal denervation for hypertension, cancer pain, and diabetes.

Founded 2013 Series D Total: $20.00M Health Care, Medical Devices

General Information

Company Name Brattea
Founded Year 2013
Founders / Decision Makers
Team member
Industries Health Care, Medical Devices
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Brattea. To contact Brattea, visit brattea.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Brattea

Brattea is a medical device research and development company that is revolutionizing renal denervation for the treatment of hypertension, cancer pain, and diabetes. Founded in 2013, the company operates within the Health Care and Medical Devices industries. Their recent Series D investment on 25 March 2024 garnered support from prominent investors such as Dingxin Capital, Shanghai Healthcare Capital, Zhongping Capital, and Morning Spring Venture. With a focus on the development and commercialization of innovative medical solutions, Brattea aims to address critical unmet medical needs effectively.

Taxonomy: Medical Device Research, Renal Denervation, Hypertension Treatment, Cancer Pain Management, Diabetes, Commercialization, Medical Technology, Healthcare Innovation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series D Undisclosed 4
Dingxin Capital Shanghai Healthcare Capital Zhongping Capital
Dingxin Capital, Shanghai Healthcare Capital +2
25 Mar 2024
Series C Undisclosed 4
Fosun International Hengxu Capital NNFE Fund Management
Fosun International, Hengxu Capital +2
22 Dec 2022
Series B $20.00M 2
Sherpa Healthcare Partners, BioVenture
06 Apr 2021

Brattea Alternatives & Competitors

View All Alternatives
Brattea vs
SyMap Medical
SyMap Medical

Crafting advanced, catheter-based systems for renal denervation therapy aimed at treating hypertensi...

Series E
1 employees
Biotechnology, Health Care
Brattea vs
ANGIO CARE
ANGIO CARE

Pioneering advanced solutions for essential hypertension with innovative single-electrode equipment...

Series B
Health Care, Medical Devices
Brattea vs
Morphic Medical
Morphic Medical United States

Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.

Post-IPO Equity
50 employees
Biotechnology, Health Care
View all alternatives

FAQ About Brattea

Pioneering advancements in renal denervation for hypertension, cancer pain, and diabetes.
Brattea was founded in 2013.
Brattea operates in Health Care and Medical Devices. Its work centres on Medical Device Research, Renal Denervation, Hypertension Treatment and Cancer Pain Management.
Brattea has completed 3 funding rounds, raising a total of $20.00M. The latest funding stage is Series D.
Top alternatives and competitors to Brattea include SyMap Medical, ANGIO CARE, Morphic Medical, Nuvaira, Inc., Auto Control Médical an A&D Company / A&D Medical Canada. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Brattea and SyMap Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Brattea, https://bouncewatch.com/company/brattea, updated 3 March 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes